Research Article

Integrated UPLC-Q-TOF-MS/MS and Network Pharmacology Approach to Investigating the Metabolic Profile of Marein of Coreopsis tinctoria Nutt.

Table 2

Characterization of metabolites after injection of marein in plasma and urine.

No.t (min)Meas. m/zPred. m/zFormulaIonDiff. (ppm)Fragment ionsMetaboliteLocation

M′07.52449.1090449.1089C21H22O11[M-H]2.66287.0523, 269.0458, 151.0034, 135.0448M′P, U
M′15.67449.1101449.1089C21H22O11[M-H]3.13287.0566, 269.0458, 151.0035, 135.0451M′-2H + 2HP, U
M′26.51545.0620545.0606C21H22O15S[M-H]2.51269.0435, 151.0064M′ + OH + SO3P, U
M′37.38545.0624545.0606C21H22O15S[M-H]3.35135.0404M′ + OH + SO3P, U
M′45.35529.0683529.0657C21H22O14S[M-H]4.91449.1099, 287.0565, 269.0458, 151.0034M′ + SO3P, U
M′56.94529.0680529.0657C21H22O14S[M-H]4.31449.1101, 287.0565, 269.0458, 151.0034M′ + SO3P, U
M′65.68463.0898463.0882C21H20O12[M-H]3.50301.0706, 287.0548, 151.0044M′-2H + OHP
M′77.38463.0876463.0882C21H20O12[M-H]−1.27287.0551, 151.0029M′-2H + OHP
M′85.70447.0943447.0932C21H20O11[M-H]2.45287.0536, 269.0446M′-2HP
M′96.18447.0942447.0932C21H20O11[M-H]2.16151.0028, 269.0459M′-2HP
M′107.38447.0947447.0932C21H20O11[M-H]3.17285.0415, 267.0301, 151.0034, 135.0448M′-2HP, U
M′118.03433.1129433.1140C21H22O10[M-H]−2.56257.0812, 151.0404, 135.0444M′-OHU
M′128.43433.1135433.1140C21H22O10[M-H]−1.04257.0812, 135.0444M′-OHU
M′139.74433.1151433.1140C21H22O10[M-H]2.65257.0821M′-OHP, U
M′146.86463.1241463.1245C21H22O10[M-H]3.47301.0721, 151.0034, 135.0448M′ + CH3P, U
M′157.23463.1257463.1245C21H22O10[M-H]2.58301.0709, 151.0027, 135.0443M′ + CH3P, U
M′169.25463.1243463.1245C21H22O10[M-H]−0.62301.0710, 151.0029, 135.0443M′ + CH3U
M′176.84419.1346419.1347C21H24O9[M-H]−0.35135.0442M′ + 2H-2OHU
M′184.85625.1429625.1410C27H30O17[M-H]3.08449.1105, 287.0561, 269.0453, 151.0035, 135.0448M′ + GluAP, U
M′195.20625.1428625.1410C27H30O17[M-H]2.91463.0875, 287.0553, 151.0028, 135.0442M′ + GluAP, U
M′206.38625.1414625.1410C27H30O17[M-H]0.68449.1089, 287.0548, 151.0027, 135.0438M′+GluAU
M′216.78625.1430625.1410C27H30O17[M-H]3.23449.1098, 287.0567, 269.0448, 151.0034, 135.0452M′ + GluAP, U
M′229.28287.0555287.0561C15H12O6[M-H]−2.13151.0051, 135.0436M′-GluAU
M′236.84477.1051477.1038C22H22O12[M-H]2.68301.0711, 151.0028, 135.0446M′-2H + OH + CH3P, U
M′247.58477.1036477.1038C22H22O12[M-H]−0.50301.0715, 151.0031, 135.0450M′-2H + OH + CH3U
M′258.64477.1049477.1038C22H22O12[M-H]2.31301.079, 151.0034, 135.0452M′-2H + OH + CH3P, U
M′269.45477.1054477.1038C22H22O12[M-H]3.27301.0723, 151.0033, 135.0449M′-2H + OH + CH3P
M′279.76477.1052477.1038C22H22O12[M-H]2.94301.0709, 151.0029M′-2H + OH + CH3P
M′285.35543.0829543.0814C22H24O14S[M-H]2.76135.0453M' + CH3 + SO3P, U
M′295.84543.0832543.0814C22H24O14S[M-H]3.44287.0559, 151.0012, 135.0454M′ + CH3 + SO3P, U
M′306.92543.0812543.0814C22H24O14S[M-H]−0.26287.0516, 135.0449M′ + CH3 + SO3U
M′317.42543.0818543.0814C22H24O14S[M-H]0.74287.0547, 151.001, 135.0432M′ + CH3 + SO3U

Note. M′0: marein, P: plasma, U: urine, and common metabolites for both modes of administration.